BioCardia Inc (BCDA) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and Promising ...

featured-image

BioCardia Inc (BCDA) reports significant expense reductions and positive clinical trial results, despite financial constraints and market challenges.

BioCardia Inc (BCDA) reports significant expense reductions and positive clinical trial results, despite financial constraints and market challenges..